Articles from Rite Aid Corporation

At Rite Aid, the health and safety of our customers and associates is our top priority. In response to the ongoing wildfires in Los Angeles, we remain committed to supporting the community and ensuring access to essential medications and clinical services. During this declared emergency, pharmacists, located within the affected and surrounding counties, are able to provide emergency refills of certain prescriptions to customers impacted by the fires.

Rite Aid today released the results of a new survey* to better understand the ways in which consumers engage with their pharmacists, and uncover additional ways pharmacists can support their overall health.

Rite Aid, one of the nation’s leading pharmacy retailers, today announced a new partnership with Klarna, the AI powered global payments network and shopping assistant, to offer Rite Aid customers the popular Pay in 4 payment option for greater flexibility in managing their purchases across all stores.

Rite Aid today announced the launch of its “Tackle the Flu” sweepstakes—another way Rite Aid is helping to promote healthy communities and encourage customers to take an active role in safeguarding their health during the upcoming flu season.

Rite Aid Corporation (“Rite Aid” or the “Company”) today announced that Matt Schroeder has been appointed Chief Executive Officer after the Company’s emergence from Chapter 11. Mr. Schroeder joined Rite Aid in 2000 and most recently served as the Company’s Chief Financial Officer. He succeeds Jeffrey S. Stein, who has stepped down as Chief Executive Officer and Chief Restructuring Officer in connection with the Company’s emergence from Chapter 11.

Rite Aid Corporation (“Rite Aid” or the “Company”) today announced that it has successfully completed its financial restructuring and emerged from Chapter 11, marking a new beginning as a stronger company with a rightsized store footprint, more efficient operating model, significantly less debt and additional financial resources.

Following FDA authorization and CDC recommendation, Rite Aid (OTC: RADCQ) today announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2024-2025) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available immediately.

Rite Aid (OTC: RADCQ) today announced that appointments for influenza (flu) and respiratory syncytial (RSV) vaccines currently are available at all store locations, including Bartell Drugs in the Pacific Northwest. Customers can now schedule appointments effective immediately for these vaccines and many others to protect themselves and family members against the upcoming respiratory virus season through Rite Aid’s online scheduler.

Rite Aid Corporation (OTC: RADCQ) is providing notice of an incident that involved certain consumers’ personal information. We are mailing letters to any potentially affected consumer who was associated with a mailing address in our systems.

Rite Aid (OTC: RADCQ) today announced its expanded partnership with Instacart (NASDAQCART), the leading grocery technology company in North America, allowing use of an Electronic Benefits Transfer (EBT) card for the Supplemental Nutrition Assistance Program (SNAP) as an online payment option for eligible items on its Instacart digital storefront. Available from over 1,400 Rite Aid and Bartell Drugs locations nationwide, this new online payment option provides seamless access to essential items Rite Aid customers need to enhance their well-being, while offering additional convenience to communities with SNAP benefits through same-day delivery.

Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations. These events offer the flexibility of a walk-in clinic, allowing families to conveniently get the vaccinations they need to protect themselves against seasonal viruses and stay current on regular ancillary vaccines.

Rite Aid (OTC: RADCQ) today announced the expansion of its delivery partnership with Uber Eats to include alcohol in new markets. Nearly 1,000 select Rite Aid stores across California, Idaho, Michigan, New York, Ohio, Oregon, Virginia and Washington are now participating in the expanded delivery, allowing more customers to shop for a wide selection of alcohol brands and enjoy the convenience of delivery to their doorsteps within minutes.

Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores. Opill is a progestin-only, daily oral contraceptive (birth control pill) that’s safe and effective when used as directed to help prevent pregnancy.

Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves. As the first retail pharmacy chain to partner with Copia, Rite Aid will donate food items leveraging Copia’s seamless surplus redistribution platform to easily track inventory, prove compliance, and record impact in real time. The platform will match Rite Aid with local nonprofit organizations focused on combating food insecurity.

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.

Rite Aid (OTC:RADCQ) recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest. The latest ACIP and CDC recommendation aims to increase vaccine protection that may have lessened in vulnerable adults.

Today, Rite Aid debuted its new ‘It Means More’ ad – spotlighting the retail pharmacy chain's commitment to its customers, together with the passion and ongoing dedication of its employees to continuously provide unrivaled customer experiences. At a time when personal connections are increasingly valued, Rite Aid is reaffirming its recognition of the importance of nurturing customer relationships and reinforcing this core company value by emphasizing its steadfast focus on creating meaningful interactions.

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has completed the previously announced sale of its Elixir Solutions business (“Elixir”) to MedImpact Healthcare Systems, Inc. (“MedImpact”) for approximately $576.5 million.

Love is in the air, and Rite Aid is ready to make this Valentine’s Day unforgettable. Whether you're expressing affection to a special someone, embracing self-care or celebrating with friends and family, Rite Aid’s shelves are stocked with a thoughtfully curated selection of gifts and treats designed to cater to every love language.

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that the U.S. Bankruptcy Court for the District of New Jersey has approved the sale of the Company’s Elixir Solutions Business to MedImpact Healthcare Systems, Inc. (“MedImpact”), an independent pharmacy benefit solutions company.

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has reached a comprehensive settlement agreement with the U.S. Federal Trade Commission (“FTC”) regarding the Company’s historical use of facial recognition technology to prevent retail theft and issues relating to the Company’s compliance with a 2010 Commission Order.

There’s no denying the holidays are an unforgettable time of year with so many seasonal staples like family gatherings, gift exchanges, recipe traditions, and even the less joyful element of stress. As celebrations take place throughout the coming weeks, Rite Aid is offering a one-stop-shop solution for cherishable memory-making that keeps the “happy” in Happy Holidays.

It’s the season to spread holiday cheer – not the flu. Throughout December, Rite Aid (OTC: RADCQ) will offer Flu Shot Fridays at select locations, providing a convenient opportunity for families to walk in or schedule appointments for the vaccinations they need to help protect themselves against the flu, COVID-19, RSV and other viruses.

Rite Aid Corporation (OTC: RADCQ) today announced that customers in California, Maryland, New Hampshire, Nevada and Oregon can now receive prescribed hormonal contraceptives by their local Rite Aid pharmacist at most store locations after completing an in-person private consultation. Pharmacists in these states have gained the authority to prescribe hormonal contraceptives depending on each state’s laws and regulations.

Rite Aid (OTC: RADCQ) is proud to recognize the service and sacrifice of all veterans and active military personnel this Veterans’ Day by offering a “Veteran Appreciation Days” promotion.

With fall routines and busy schedules in full swing, it can be tough to focus on your health. Rite Aid (OTC: RADCQ) makes it easy to keep your health a priority by offering an After Work Wednesday clinic at select stores, providing families a convenient opportunity to walk in and get the immunizations they need to protect themselves against the flu, COVID-19, RSV, and other viruses.

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has received approvals from the U.S. Bankruptcy Court for the District of New Jersey for its “First Day” motions related to the Company’s voluntary Chapter 11 petitions filed on October 15, 2023.

Rite Aid Corporation (NYSERAD) (“Rite Aid” or the “Company”) today announced it has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the Company to accelerate its ongoing business transformation. Implementing the contemplated restructuring plan will significantly reduce the Company’s debt, increase its financial flexibility and enable it to execute on key initiatives. In connection with this, Rite Aid has initiated a voluntary court-supervised process under Chapter 11 of the U.S. Bankruptcy Code.

Rite Aid Corporation (NYSERAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth (“Busy”) Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company’s Board.

Fall's arrival brings both the bustling return to routine and the unwelcome beginning of respiratory illness season, but getting vaccinated can be a seamless family affair. Rite Aid (NYSERAD) will offer a Family Immunization Day at select stores providing families a convenient opportunity to walk in and get the vaccinations they need to protect themselves against the flu, COVID-19, RSV, and other viruses.

Rite Aid Corporation (NYSERAD) (the “Company”) announced today that the New York Stock Exchange (the “NYSE”) informed the Company that it is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B (the Minimum Market Capitalization Standard), and Section 802.01C (the Minimum Stock Price Standard) of the NYSE’s Listed Company Manual.

Rite Aid (NYSERAD) today announces the arrival of Ello Market™ to its shelves – the national drug store chain’s new exclusive collection of quality snacks and indulgent treats to satisfy cravings as well as pantry staples to transform your meals.

Following FDA authorization and CDC recommendation, Rite Aid (NYSERAD) today announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2023-2024) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available beginning on Friday, September 22.

Rite Aid (NYSERAD) announced today that NARCAN® Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN® Nasal Spray can be purchased over the counter without a prescription.

As August marks Immunization Awareness Month, Rite Aid (NYSERAD) today announced appointments for flu and RSV vaccines are available at all store locations, including Bartell Drugs in the Pacific Northwest. Customers can now schedule appointments to protect themselves and family members against the upcoming respiratory virus season through Rite Aid’s online scheduler.

Rite Aid (NYSERAD) today published its fifth annual Environmental, Social and Governance (ESG) Report, detailing the company’s initiatives, focus areas, and progress over the past year. The four ESG pillars introduced in the 2021 report – Thriving Planet, Thriving Business, Thriving Workplace and Thriving Community – continue to act as the lens through which Rite Aid approaches its ESG commitments, and the disclosure in the voluntary report is intended to align with the Sustainability Accounting Standards Board (SASB) framework.

Rite Aid Corporation (NYSERAD) today reported operating results for its first fiscal quarter ended June 3, 2023.

Rite Aid Corporation (NYSERAD) will release financial results for its Fiscal 2024 First Quarter, which ended June 3, 2023, on Thursday, June 29, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.

Rite Aid (NYSERAD) today announced that Thomas Sabatino has joined the company as Executive Vice President and Chief Legal Officer. Sabatino will play a pivotal role in the company’s growth strategy to help create meaningful customer, client, and member experiences for millions of Americans. As Chief Legal Officer, he will oversee the organization’s legal affairs, including enterprise risk management, compliance, regulatory affairs, and privacy.

Today national drug store chain Rite Aid announced the launch of RYSHI™ – its exclusive collection of clean beauty and personal care essentials designed to let the real you shine through. Spanning across multiple categories, RYSHI™ products offer better-for-you ingredients at an accessible price point so customers can conveniently build their beauty toolkit at their neighborhood Rite Aid.

It’s no secret seasonal allergies are here. From runny noses and itchy eyes to tissues carried in all pockets and bags, spring has sprung and mother nature has brought the dreaded sneeze with her. To help its suffering shoppers, Rite Aid has spent the last few weeks dusting off last season’s sales data* and speaking with real allergy victims to once and for all ‘Ease the Sneeze.’

Rite Aid Corporation (NYSERAD) today reported operating results for its fourteen-week fourth quarter and fifty-three-week fiscal year ended March 4, 2023.

Rite Aid Corporation (NYSERAD) will release financial results for its Fiscal 2023 Fourth Quarter, which ended March 4, 2023, on Thursday, April 20, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.

Rite Aid Corporation (NYSERAD) (“Rite Aid” or the “Company”) announced today that its Board of Directors has appointed Elizabeth (“Busy”) Burr, a member of the Company’s Board, as interim CEO, effective immediately. Burr’s appointment follows Heyward Donigan’s departure from the Company as President and CEO, and as a member of the Board. Rite Aid has initiated a search to identify a permanent CEO and has retained a leading executive search firm.

Rite Aid Corporation (NYSERAD) today reported operating results for its third fiscal quarter ended November 26, 2022.

Following FDA authorization and new CDC recommendations, select Rite Aid (NYSERAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering the Pfizer-BioNTech bivalent COVID-19 Vaccine to children ages 3 and over. Rite Aid pharmacists are trained to administer vaccines 3 and older.

Rite Aid Corporation (NYSERAD) will release financial results for its Fiscal 2023 Third Quarter, which ended Nov. 26, 2022, on Wednesday, December 21, 2022. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.

Rite Aid Corporation (NYSERAD) (“we,” “us,” “our” or the “Company”) today announced the results, as of 5:00 p.m., New York City time, on November 22, 2022 (the “Early Tender Deadline”), of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $200 million aggregate purchase price (not including any accrued and unpaid interest, and as such amount may be increased or decreased by the Company, the “Aggregate Maximum Purchase Price”) of the Company’s outstanding 7.500% Senior Secured Notes due 2025 (the “Notes”). The terms and conditions of the Tender Offer are described in an Offer to Purchase and Consent Solicitation Statement, dated November 3, 2022, as supplemented on November 18, 2022 and as amended by this press release (as amended and supplemented, the “Offer to Purchase”).

Rite Aid Corporation (NYSERAD) (“we,” “us,” “our” or the “Company”) today announced the results, as of 5:00 p.m., New York City time, on November 17, 2022 (the “Original Early Tender Deadline”) of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $200 million aggregate purchase price (not including any accrued and unpaid interest, the “Aggregate Maximum Purchase Price”) of the Company’s outstanding 7.500% Senior Secured Notes due 2025 (the “Notes”). The Company also announced that it is (i) extending the Original Early Tender Deadline and withdrawal deadline to 5:00 p.m., New York City time, on November 22, 2022, unless further amended in the Company’s sole discretion (as extended hereby, the “Early Tender Deadline” and “Withdrawal Deadline,” respectively), (ii) waiving the Financing Condition (as defined below) and (iii) terminating the Consent Solicitation (as defined below). The final expiration time of the Tender Offer will also be extended and the Tender Offer will expire immediately after 11:59 p.m., New York City time, on December 7, 2022, unless further extended or earlier terminated by the Company (the “Expiration Time”). The Company does not intend to make any further amendments or changes to the Tender Offer.

Rite Aid (NYSERAD) announced today that President and CEO Heyward Donigan and CFO Matt Schroeder will present at the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, California, on November 9th at 4:25 p.m. Eastern Time. The presentation can be viewed live via webcast accessible on Rite Aid’s Investor Relations site: https://investors.riteaid.com/overview/default.aspx.

Rite Aid Corporation (NYSERAD) (“we,” “us,” “our” or the “Company”) today announced that it has commenced a tender offer (the “Tender Offer”) to purchase for cash up to $200 million aggregate purchase price (not including any accrued and unpaid interest, and as such amount may be increased or decreased by the Company, the “Aggregate Maximum Purchase Price”) of the Company’s outstanding 7.500% Senior Secured Notes due 2025 (the “Notes”).

As the U.S. Centers for Disease Control & Prevention (CDC) warns of early increases in seasonal influenza cases, Rite Aid (NYSERAD) addresses common misperceptions about vaccination and stresses the importance of staying up to date on flu and COVID-19 vaccinations before Halloween.

With flu and respiratory illnesses expected to increase during fall and winter months, Rite Aid (NYSERAD) is making diagnostic testing easier for Michigan customers with rapid point-of-care testing now available at all stores throughout the state.

Rite Aid Corporation (NYSERAD) today reported operating results for its second fiscal quarter ended August 27, 2022.

Rite Aid Corporation (NYSERAD) will release financial results for its Fiscal 2023 Second Quarter, which ended Aug. 27, 2022, on Thursday, Sept. 29. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.

Rite Aid (NYSERAD) today announced that scheduling is now available for the updated boosters of the mRNA Pfizer and Moderna COVID-19 vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest.

Rite Aid Corporation (NYSERAD) today announced that Heyward Donigan, president and chief executive officer, and Matt Schroeder, chief financial officer, will host a virtual retail shareholder investor event at 11 a.m. ET, Aug. 24. The call will be broadcast via the Internet at https://investors.riteaid.com.

It’s not too early to schedule your flu shot. Rite Aid (NYSERAD) has opened online scheduling for flu shots at its locations including Bartell Drugs in the Pacific Northwest, and is now accepting walk-ins, providing convenient options for families to get vaccinated.

Rite Aid (NYSERAD) today published its fourth annual Environmental, Social and Governance (ESG) Report, detailing the company’s strategy and progress against goals over the past year. This year’s report addresses the four ESG pillars introduced in the company’s 2021 report: Thriving Planet, Thriving Business, Thriving Workplace and Thriving Community.

Rite Aid (NYSERAD) today announced it is collaborating with Quest Diagnostics NYSE: DGXNYSEDGX)

Rite Aid Corporation (NYSERAD) (“Rite Aid” or the “Company”) announced today the early tender results of its previously announced series of tender offers (the “Tender Offers”) to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the “Maximum Aggregate Cap”). The Tender Offers are being made pursuant to the terms and conditions set forth in the Offer to Purchase, dated June 13, 2022 (the “Offer to Purchase”). The Company refers investors to the Offer to Purchase for the complete terms and conditions of the Tender Offers.

Rite Aid Corporation (NYSERAD) today reported operating results for its first fiscal quarter ended May 28, 2022.

Following FDA authorization and new CDC recommendations, select Rite Aid (NYSERAD) locations – including Bartell Drugs, owned by Rite Aid Corporation, will be providing Pfizer-BioNTech COVID-19 vaccines to children ages 3 and over once shipments arrive to select pharmacies later this week. Rite Aid pharmacists are trained to administer vaccines down to the age of 3.

Rite Aid Corporation (NYSERAD) (“Rite Aid” or the “Company”) announced today the commencement of a series of tender offers to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the “Maximum Aggregate Cap”).

Rite Aid Corporation (NYSERAD) said today that it will release financial results for its Fiscal 2023 First Quarter, which ended May 28, 2022, on Thursday, June 23, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com.

Rite Aid (NYSERAD) today announced it will begin administering a booster dose of Pfizer’s COVID-19 vaccine at select locations for eligible children ages 5 to 11, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) on Thursday. Bartell Drugs, owned by Rite Aid Corporation, will also begin administering boosters to this age group at select Seattle and Western Washington locations.

Rite Aid (NYSERAD) today announced that nearly 98% of its retail pharmacies across the 17 states it serves now offers FDA-authorized COVID-19 oral antiviral medications, Pfizer’s Paxlovid or Merck’s Molnupiravir, with a prescription from their healthcare provider.

Rite Aid Corporation (NYSERAD) confirmed that it previously rejected a non-binding, off-market proposal from Spear Point Capital Management (“Spear Point”) to acquire all of the outstanding shares of the Company’s common stock. The Company and its Board of Directors reviewed the proposal with the assistance of its financial and legal advisors, and the Board concluded that the proposal was not credible and did not warrant further exploration.

Rite Aid Corporation (NYSERAD) today reported operating results for its fourth quarter and fiscal year ended February 26, 2022.

Rite Aid Corporation (NYSERAD) said today that it will release financial results for its Fiscal 2022 Fourth Quarter, which ended February 26, 2022, on Thursday, April 14, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid’s management team. The call will be broadcast via the Internet at https://investors.riteaid.com.

Free N95 non-surgical masks are now available at many of Rite Aid’s locations across the country and are expected to be in most all locations this week. The masks are free of charge through the federal government’s distribution program to provide them to all Americans who want them. Customers can pick up the masks – with a limit of 3 per customer – at any Rite Aid location as long as supplies last.

Rite Aid Corporation (NYSERAD) today reported operating results for its third fiscal quarter ended November 27, 2021.

Rite Aid Corporation (NYSERAD) said today that it will release financial results for its Fiscal 2022 Third Quarter, which ended Nov. 27, 2021, on Tuesday, Dec. 21, 2021. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com.

On November 2, 2021, the Centers for Disease Control and Prevention (CDC) concurred with previous recommendations made by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP), officially authorizing the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.

Rite Aid Corporation (NYSERAD) announced today that Heyward Donigan, president and chief executive officer; Jim Peters, chief operating officer and Matt Schroeder, executive vice president and chief financial officer will participate in a fireside chat with investors at the 30th Annual Credit Suisse Healthcare Conference on Wednesday, Nov. 10th at approximately 9:40 a.m. ET.